The Latest Breaking News from diabetes

California plans to make its own insulin

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Lifesaving medication for cancer, heart disease and diabetes is growing scarcer and more expensive as the economic crisis intensifies

Exclusive: New scheme for subsidised monitoring devices stipulates only diabetes specialists can certify patient access

A research group completed their food intake no later than 6pm

Restricting eating times could help counteract the negative effects of eating throughout the day, researchers say.

In camps like Mahama in Rwanda, cases of non-communicable diseases such as stroke and renal failure are growing – and even children are affected

A volunteer firefighter who has been stripped of frontline duties by the CFA fears her brigade will now struggle to get their fire truck out the door.

Diabetes researchers say they have made a breakthrough that could pave the way to eliminating the need for daily insulin injections.